Skip to content
  • As opioid deaths rise, pharma firm hikes price of antidote more than six-fold

    Philly.com - 01/30/2017

    Still, experts say the device’s price surge is way out of step with production costs, and a needless drain on health-care resources.

    “There’s absolutely nothing that warrants them charging what they’re charging,” said Leo Beletsky, an associate professor of law and health sciences at Northeastern University in Boston.

  • Cookies on Northeastern sites

    This website uses cookies and similar technologies to understand your use of our website and give you a better experience. By continuing to use the site or closing this banner without changing your cookie settings, you agree to our use of cookies and other technologies. To find out more about our use of cookies and how to change your settings, please go to our Privacy Statement.